[Central antimuscarinic cholinergic effects of scopolamine and other cholinergic antagonists].
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002375:Catalepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D010276:Parasympatholytics / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011976:Receptors, Muscarinic / Q000187:drug effects* / Q000378:metabolism; D012601:Scopolamine / Q000494:pharmacology*
D010276:Parasympatholytics; D011976:Receptors, Muscarinic; D011813:Quinuclidinyl Benzilate; D012601:Scopolamine